血栓抽吸导管对急性心肌梗死介入治疗无复流现象作用的临床观察被引量：5

下载PDF

导出

摘要目的研究评价PCI治疗急性心肌梗死患者时使用血栓抽吸导管的临床疗效。方法选取2014年1月至2015年8月我院符合急诊PCI条件的急性心肌梗死患者共40例,平均分为两组(血栓抽吸组与单纯介入组),血栓抽吸组在PCI术中使用血栓抽吸导管,单纯介入组实施常规PCI治疗。通过术后TIMI血流分级评价冠状动脉再通情况。结果 PCI术后抽吸组TIMI血流3级患者共18例,占90.0%,TIMI血流2级患者2例,占10.0%;对照组TIMI血流3级患者9例,占45.0%,TIMI血流2级患者6例,占30.0%。两组相比,术后TIMI血流3级血流患者抽吸组明显多于对照组,差异有统计学意义,术后TIMI血流2级血流患者两组间无明显统计学差异。结论对急性心肌梗死患者行急诊PCI中适宜的应用血栓抽吸导管能显著减少急性心肌梗死患者再灌注治疗后无复流现象的发生,能有效改善IRA的TIMI血流分级。

作者陈庆

机构地区北京市通州区中医院

出处《中国医药指南》 2016年第1期114-115,共2页 Guide of China Medicine

关键词急性心肌梗死无复流现象血栓抽吸导管介入治疗

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1Burzotta F,Trani C,Romagnoli E,et al.A Pilot Study with A New Rapid-exchange Thrombus-aspirating Device in Patients with Thrombus-containing Lesions:the Diver C.E.Study[J].Catheter Cardiovasc Interv,2006,67(6):887-893.
2冼伟进,余泽洪,陈小林,何北海,汤立军,邹袆,区转焕,梁美合.血栓抽吸导管联合经抽吸导管冠状动脉内注射替罗非班在急性心肌梗死急诊介入中应用的临床研究[J].中国综合临床,2012,28(7):694-697. 被引量：18
3Kloner RA,Canote CE,Jenning RB.The“no-reflow”phenomenon after temporary coronary occlusion in the dog[J].J Clin Invest,1974,57(6):1496-1508.
4Rezkalla SH,K loner R A.Coronar y no-ref low phenomenon:from the experimental laboratory to the cardiac catheterization laboratory[J].Catheter Cardiovasc Interv,2009,72(7):950-957.
5Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanisms and therapies[J].Eur Heart J,2001,22(9):729-739.
6甘立军,廖玉华,李传方,程云涛,曹勇.不同措施干预心肌梗死患者PCI术中无复流现象的远期疗效[J].中国循证心血管医学杂志,2014,6(1):76-79. 被引量：11
7吴玉红.急性ST段抬高型心肌梗死(STEMI)急诊PCI术中应用抽吸导管临床研究[J].临床医学,2015,28(20):32-33.

二级参考文献20

1Movahed MR,Butman SM. The pathogenesis and treatment of no- reflow occurring during percutaneous coronary intervention [J]. Cardiovasc Revasc Med ,2008,9 ( 1 ) :56-61.
2Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) : a 1-year follow-up study [ J]. Lancet, 2008,371 (9628) : 1915-1920.
3Burzotta F, De Vita M, Gu YL, et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials [ J ]. Eur Heart J,2009,30(18) :2193-2203.
4Nagata Y, Usuda K, Uchiyama A, et al. Characteristics of the pathological images of coronary artery thrombi according to theinfarct-related coronary artery in acute myocardial infarction [ J ]. Circ J,20(0,68(4) :308-314.
5Bolognese L,Carrabba N,Parodi G,et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction[J]. Circulation,2004,109(9): 1121-6.
6Galiuto L,Garramone B,Scara A,et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: Results of the multicenter AMICI study[J]. J Am Coll Cardiol,2008,51 (5):552-9.
7Pollack C Jr. Pharmacological and mechanical revascularization strategies in STEMI: integration of two approaches[J]. J Invasive Cardiol,2008,20(5):231-8.
8Hassan AK,Liem SS,van der Kley F,et al. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure. Results from the Leiden MISSION! acute myocardial infarction treatment optimization program[J]. Catheter Cardiovasc Interv,2009,74(2):335-43.
9Svilaas T,Vlaar PJ,van der Horst IC,et al. Thrombus aspirationduring primary percutaneous coronary intervention[J]. N Engl J Med,2008,358(6):557-67.
10Bavry AA,Kumbhani DJ,Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: A comprehensive meta-analysis of randomized trials[J]. Eur Heart J,2008,29(24):2989-3001.